Articles From: T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum to New study involving 10 canadian research sites shows high cure rates for genotype 1 hepatitis C using new Bristol-Myers Squibb all-oral daclatasvir TRIO fixed-dose combination


LEXINGTON, Mass., Nov.
Sign-up for T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978686001&sourceType=1 http://www.ccnmatthews.com/logos/20111003-advlogful.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Alderon Appoints Two New Hebei Directors to the Board investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at the following upcoming investor conferences: Live, listen-only webcasts of the presentations may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com .
Sign-up for Foundation Medicine to Present at Upcoming Investor Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978714001&sourceType=1 http://media3.marketwire.com/logos/20130113-cgi_logo_b.jpg MONTREAL, QUEBEC --
Sign-up for CGI posts strong Q4 and fiscal 2014 results investment picks
sPower and Camborne Capital Receive More Than 105,500 High Efficiency Honey M solar Modules from Trina Solar CHANGZHOU, China , Nov.
Sign-up for Trina Solar Supplies 28.5MW of Modules to Large-Scale Projects in UK investment picks
NETANYA, Israel , November 13, 2014 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel ltd. Announces Annual General Meeting of Shareholders investment picks
2014/11/13
Amec Foster Wheeler - a new force in global engineering, project delivery, asset support, power equipment and consultancy is unveiled and leadership team confirmed Canada NewsWire 2013 annualised scope revenue of £5.5 billion (1) and order book of £6.3 billion (2) Combined, highly skilled workforce of over 40,000 people in 50 countries Strong presence across oil and gas sector Management team for four business units confirmed LONDON, UK , Nov.
Sign-up for Amec Foster Wheeler - a new force in global engineering, project delivery, asset support, power equipment and consultancy is unveiled and leadership team confirmed investment picks
SANTA MONICA, Calif.
Sign-up for Macerich To Host Investor Day investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978681001&sourceType=1 http://media3.marketwire.com/logos/20140521-CINEP.jpg TORONTO, ONTARIO --
Sign-up for Cineplex Inc. Reports Third Quarter Results investment picks
2014/11/13
By David Weidner, MarketWatch The financial media pull out the thesaurus to glorify the Wall Street millionaires SAN FRANCISCO (MarketWatch) -- Apologies in advance.
Sign-up for UPDATE: Why Goldman Sachs' partners are better than you investment picks
Ascent Solar Technologies, Inc. (“Ascent”) (NASDAQ:ASTI), a manufacturer of state-of-the-art, flexible thin-film photovoltaic modules, integrated into off-grid applications and the company’s EnerPlex™ series of consumer products, announced today the Company’s third quarter results ended September 30, 2014.
Sign-up for Ascent Solar Announces Q3 Results and Reiterates Full Year Revenue Guidance of $5 - $6 Million Dollars investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978760001&sourceType=1 http://media3.marketwire.com/logos/20130820-Zinc.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Canadian Zinc Reports Financial Results for Third Quarter 2014 investment picks
2014/11/13
Premier to focus on open pit opportunities at McCoy-Cove Property Canada NewsWire THUNDER BAY, ON , Nov.
Sign-up for Premier to focus on open pit opportunities at McCoy-Cove Property investment picks
Mallinckrodt plc (NYSE: MNK) has been informed by the U.S. Food and Drug Administration (FDA) that the agency has reason to believe that the company’s methylphenidate hydrochloride extended-release (ER) tablets, USP (CII) may not be therapeutically equivalent to the category reference drug Concerta®. As a result, the agency indicated that it has reclassified Mallinckrodt’s ANDA 202608 for methylphenidate ER dosage strengths of 27mg, 36 mg and 54 mg from AB (freely substitutable at the pharmacy level) to BX (presumed to be therapeutically inequivalent). The agency said that this change was based on the application of its new Draft Guidance for determining bioequivalence of methylphenidate hydrochloride products just published on November 6, 2014.
Sign-up for Mallinckrodt plc Responds to FDA’s Expected Reclassification of Methylphenidate ER investment picks
Pro Forma Results: - Adjusted Net Income of $35.5 Million or $0.40 per Fully Diluted Share for the Third Quarter; $116.2 Million or $1.31 per Fully Diluted Share for the First Nine Months 2014 - Adjusted EBITDA of $57.8 Million for the Third Quarter; $193.7 Million for the First Nine Months 2014 Assets Under Administration of $212.8 Billion; up 11.3% From the Year Ago Period Following Review by Independent External Counsel and Forensic Accounting Firm, RCS Capital's Audit Committee and Management Team Remain Confident in The Company's Reported Historical Financials, Accounting, and Internal Controls $57 - $65 Million Revenue Synergies and Cost Savings Expected to be in Place for January 1, 2015; Additional Synergies Expected in 2015 9,139 Total Advisors on Platform; 97.8% Annualized Advisor Retention; Solid Retail Margin Expansion in Third Quarter; Robust Recruiting Pipeline Wholesale Distribution Equity Sales of $2.3 Billion for the Third Quarter; $8.2
Sign-up for RCS Capital Corporation Announces Third Quarter 2014 Operating Results investment picks
SHENZHEN, China , Nov.
Sign-up for CNIT Secures RMB 1 Billion Revolving Credit Line with China CITIC Bank investment picks
Evaluation based on ability to execute and completeness of vision ST.
Sign-up for Amdocs Positioned in Leader's Quadrant for Integrated Revenue and Customer Management (IRCM) for CSPs investment picks
ROSH HAAYIN, Israel , Nov.
Sign-up for Pointer Telocation Reports Q3 2014 Financial Results investment picks
Net Cash from operating activities of NIS 9.1 million (US$ 2.5 million) in Q3 2014 YAVNE, Israel , Nov.
Sign-up for G. Willi-Food Reports Q3 2014 Sales Up 0.1% From Q3 2013 Sales investment picks
2014/11/13
TULSA, Okla., Nov.
Sign-up for Helmerich & Payne, Inc. Announces Fiscal Year-End Results and Additional New Build Contracts investment picks
2014/11/13
NEWTON, Mass., Nov.
Sign-up for TripAdvisor Introduces New Feature to Help Travelers Research, Compare and Book Tours investment picks
2014/11/13
SHENZHEN, China , Nov.
Sign-up for Mindray to Hold Annual General Meeting in Hong Kong on December 10, 2014 investment picks
New study involving 10 canadian research sites shows high cure rates for genotype 1 hepatitis C using new Bristol-Myers Squibb all-oral daclatasvir TRIO fixed-dose combination Canada NewsWire MONTREAL , Nov.
Sign-up for New study involving 10 canadian research sites shows high cure rates for genotype 1 hepatitis C using new Bristol-Myers Squibb all-oral daclatasvir TRIO fixed-dose combination investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum to New study involving 10 canadian research sites shows high cure rates for genotype 1 hepatitis C using new Bristol-Myers Squibb all-oral daclatasvir TRIO fixed-dose combination
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent